Publications by authors named "Jeffrey A Zonder"

37Publications

Exportin 1 inhibition as antiviral therapy.

Drug Discov Today 2020 Jun 20. Epub 2020 Jun 20.

Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2020.06.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305737PMC
June 2020

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Blood Adv 2020 01;4(1):181-190

Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960456PMC
January 2020

The difficult business of assessing new therapies for smouldering multiple myeloma.

Authors:
Jeffrey A Zonder

Br J Haematol 2018 08 16;182(4):463-464. Epub 2018 May 16.

Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15385DOI Listing
August 2018

Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma.

Blood Lymphat Cancer 2017 19;7:53-60. Epub 2017 Jul 19.

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S82444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467339PMC
July 2017

Transplantation for Myeloma - Now or Later?

N Engl J Med 2017 04;376(14):1378-1379

From the Division of Hematology-Oncology, Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1700453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860019PMC
April 2017

The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.

Expert Opin Drug Discov 2017 Feb 20;12(2):225-235. Epub 2016 Dec 20.

a Department of Oncology , Wayne State University School of Medicine , Detroit , Michigan , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2017.1268596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520581PMC
February 2017

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:
Kristin A Rand Chi Song Eric Dean Daniel J Serie Karen Curtin Xin Sheng Donglei Hu Carol Ann Huff Leon Bernal-Mizrachi Michael H Tomasson Sikander Ailawadhi Seema Singhal Karen Pawlish Edward S Peters Cathryn H Bock Alex Stram David J Van Den Berg Christopher K Edlund David V Conti Todd Zimmerman Amie E Hwang Scott Huntsman John Graff Ajay Nooka Yinfei Kong Silvana L Pregja Sonja I Berndt William J Blot John Carpten Graham Casey Lisa Chu W Ryan Diver Victoria L Stevens Michael R Lieber Phyllis J Goodman Anselm J M Hennis Ann W Hsing Jayesh Mehta Rick A Kittles Suzanne Kolb Eric A Klein Cristina Leske Adam B Murphy Barbara Nemesure Christine Neslund-Dudas Sara S Strom Ravi Vij Benjamin A Rybicki Janet L Stanford Lisa B Signorello John S Witte Christine B Ambrosone Parveen Bhatti Esther M John Leslie Bernstein Wei Zheng Andrew F Olshan Jennifer J Hu Regina G Ziegler Sarah J Nyante Elisa V Bandera Brenda M Birmann Sue A Ingles Michael F Press Djordje Atanackovic Martha J Glenn Lisa A Cannon-Albright Brandt Jones Guido Tricot Thomas G Martin Shaji K Kumar Jeffrey L Wolf Sandra L Deming Halverson Nathaniel Rothman Angela R Brooks-Wilson S Vincent Rajkumar Laurence N Kolonel Stephen J Chanock Susan L Slager Richard K Severson Nalini Janakiraman Howard R Terebelo Elizabeth E Brown Anneclaire J De Roos Ann F Mohrbacher Graham A Colditz Graham G Giles John J Spinelli Brian C Chiu Nikhil C Munshi Kenneth C Anderson Joan Levy Jeffrey A Zonder Robert Z Orlowski Sagar Lonial Nicola J Camp Celine M Vachon Elad Ziv Daniel O Stram Dennis J Hazelett Christopher A Haiman Wendy Cozen

Cancer Epidemiol Biomarkers Prev 2016 12 1;25(12):1609-1618. Epub 2016 Sep 1.

Keck School of Medicine of USC and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-1193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524541PMC
December 2016

Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Curr Cancer Drug Targets 2014 ;14(6):517-36

Barbara Ann Karmanos Cancer Institute and Department of Oncology, Wayne State University School of Medicine, 540.1 HWCRC, 4100 John R Road, Detroit, MI 48201.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279864PMC
http://dx.doi.org/10.2174/1568009614666140804154511DOI Listing
May 2015

Secondary primary malignancies in multiple myeloma: an old NEMESIS revisited.

Adv Hematol 2012 19;2012:801495. Epub 2012 Jul 19.

Department of Oncology, Karmanos Cancer Institute and Wayne State University, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/801495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407607PMC
August 2012

Clinical development of novel proteasome inhibitors for cancer treatment.

Expert Opin Investig Drugs 2009 Jul;18(7):957-71

The Prevention Program, Barbara Ann Karmanos Cancer Institute, and the Department of Pathology, School of Medicine, Wayne State University, 540.1 HWCRC, 4100 John R. Road, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1517/135437809030020
Publisher Site
http://dx.doi.org/10.1517/13543780903002074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758888PMC
July 2009

Thrombotic complications of myeloma therapy.

Authors:
Jeffrey A Zonder

Hematology Am Soc Hematol Educ Program 2006 :348-55

Division of Hematology-Oncology, Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2006.1.348DOI Listing
June 2007

Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.

Curr Hematol Malig Rep 2006 Sep;1(3):141-51

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R., Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-996-0002-yDOI Listing
September 2006

Practical aspects of the treatment of chronic myelogenous leukemia with imatinib mesylate.

Curr Hematol Rep 2003 Jan;2(1):57-64

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Harper Hospital, 4 Brush South, 3990 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
January 2003

Chronic lymphocytic leukemia presenting in association with aplastic anemia.

Am J Hematol 2002 Dec;71(4):323-7

Division of Hematology-Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.10226DOI Listing
December 2002